Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Potential Rise

<< Previous

Bullboard Posts

Next >>

Comment by consultant99on Feb 06, 2023 1:03pm

288 Views

Post# 35269594

RE:RE:Potential Rise

Interesting point raised about more than 2 treatments.

I have wondered if any patients so far that were NR after their first treatment achieved PR or CR after a second treatment. If not is this a limitation for the technology

I also wonder why after 450 days the CR rate drops below the 90 day level even though patients that did achieve CR go through a second treatment.

I thought there was the potential for an immune response; I wonder what the outcome was for those patients in the trial after 450 days.. Would the company or the FDA have access to the information?

<< Previous

Bullboard Posts

Next >>

Sony’s Alpha 1 II: A new professional photography standard?